22-23 November 2018
Australian Synchrotron
Australia/Melbourne timezone
Registrations & Abstracts have closed

Cholesterol-Dependent Cytolysins: from Water-Soluble State to Membrane Pore

23 Nov 2018, 12:00
30m
Monash Biomedical Imaging Auditorium

Monash Biomedical Imaging Auditorium

Oral Structural Biology Parallel Session 12

Speaker

Prof. Michael Parker (Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria 3010, Australia and St. Vincent’s Institute of Medical Research, Victoria 3065, Australia.)

Description

Cholesterol-dependent cytolysins (CDCs) are a family of pore-forming toxins that punch holes in the outer membrane of eukaryotic cells. The CDCs exhibit a number of unique features amongst pore-forming toxins including an absolute dependence on the presence of cholesterol-rich membranes for their activity and the formation of oligomeric transmembrane pores greater than 150 Å in diameter. The first crystal structure of a CDC was that of perfringolysin O [1] and most of our understanding of CDC function is based on studies of this toxin [2-4]. We have subsequently determined structures of other family members that have confirmed that the 3D fold first seen in PFO is shared by all family members [5-9]. We have determined a number of CDC structures which are providing valuable insights into the role of receptor binding, oligomerisation and prepore assembly [8,9]. The conversion from water-soluble monomer to pore is highly complex: it is essential that the pore does not form prematurely otherwise the target cell won’t be successfully breached [10]. The crystal structures of the water-soluble states of these toxins, together with cryo-electron microscopy, small angle X-ray scattering data, fluorescence spectroscopy and molecular dynamics simulations have proved very useful for modelling their membrane pores.

[1] J. Rossjohn et al., Cell 89, 685 (1997).
[2] O. Shatursky et al., Cell 99, 293 (1999).
[3] R.J. Gilbert et al., Cell 97, 647 (1999).
[4] M.P. Christie et al., Biophys. Revs., in press (2018)
[5] G. Polekhina et al., PNAS 102, 600 (2005).
[6] S.C. Feil et al., Structure 20, 248 (2012).
[7] S.C. Feil et al., J. Mol. Biol. 426, 785 (2014).
[8] S.L. Lawrence et al., Sci. Reps. 5, 14352 (2015).
[9] S.L. Lawrence et al., Structure 5, 1488 (2016).
[10] K.R. Wade et al., Proc. Natl., Acad. Sci. 112, 2204 (2015).

Primary authors

Dr Craig Morton (Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne) Dr Sara Lawrence (Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne) Dr Michelle Christie (Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne) Ms Bronte Johnstone (Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne) Prof. Rodney Tweten (Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center ) Prof. Michael Parker (Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria 3010, Australia and St. Vincent’s Institute of Medical Research, Victoria 3065, Australia.)

Presentation Materials

There are no materials yet.
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×